Request Demo
Last update 05 Apr 2026
BFB-759
Last update 05 Apr 2026
Overview
Basic Info
Drug Type Monoclonal antibody |
Synonyms BFB-759 |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 2/3 |
First Approval Date- |
Regulation- |
Login to view timeline
Structure/Sequence
Sequence Code 18386
Sequence Code 40314
Sequence Code 9158641
Sequence Code 9590734
Sequence Code 10043821
Sequence Code 432618265VH
Sequence Code 432618266
Sequence Code 432618267VL
Related
4
Clinical Trials associated with BFB-759CTIS2025-522440-41-00
A Phase 2, Dose Ranging, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of BFB759 in Patients with Moderate to Severe Hidradenitis Suppurativa (COMPASS 2 - HS)
CTIS2025-521624-30-00
A Phase 2, Parallel-arm, Randomized, Double-blind, Placebo-controlled, Dose-ranging Study to Evaluate the Efficacy and Safety of BFB759 in Patients with Atopic Dermatitis (COMPASS 2-AD)
NCT07287644
A Phase 2, Dose Ranging, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of BFB759 in Patients With Moderate to Severe Hidradenitis Suppurativa
100 Clinical Results associated with BFB-759
Login to view more data
100 Translational Medicine associated with BFB-759
Login to view more data
100 Patents (Medical) associated with BFB-759
Login to view more data
100 Deals associated with BFB-759
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Hidradenitis Suppurativa | Phase 3 | United States | 03 Nov 2025 | |
| Hidradenitis Suppurativa | Phase 3 | Canada | 03 Nov 2025 | |
| Dermatitis, Atopic | Phase 2 | United States | 15 Jul 2025 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Biosimilar
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free